Botulinum toxin in psoriasis

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

TCTR

Registry ID

TCTR20180703004

Enrollment

Unknown

Registered

2018-07-03

Start date

2018-08-05

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

scalp psoriasis scalp psoriasis

Interventions

botox injection to psoriasis lesion

Experimental Drug

botox

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: scalp psoriasis patient

Exclusion criteria

Exclusion criteria: pregnancy, breastfeeding

Design outcomes

Primary

Measure	Time frame
change of lesions after botox injection at week 0, 4, 8, 12 mPASI	—

Secondary

Measure	Time frame
side effect after botox injection at week 4 questionare	—

Countries

thailand

Contacts

Public Contactjenvajee khamthara

Faculty of medicine, Chulalongkorn university

why_jane@hotmail.com081-5951368

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026